# MOMETASONE FUROATE
> **ANDA215878** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2024-03-18
## Drug
- **FDA Application Number:** ANDA215878
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MOMETASONE FUROATE
- **Generic name:** MOMETASONE FUROATE MONOHYDRATE
- **Active ingredients:** MOMETASONE FUROATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2024-03-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215878)
---
*MORVS · CC0 1.0*